Altasciences has been chosen by Virpax Pharmaceuticals, Inc. to conduct nonclinical studies to support the development of quaternary ammonium palmitoyl glycol chitosan (GCPQ, under the trade name of AnQlar). AnQlar is a nanoparticle intended to help prevent the spread of negatively charged viruses such as COVID-19 and influenza via intranasal spray and has been shown to inhibit the ability of the virus to replicate at non-toxic concentrations. In development since 2022, the project has comple...